Kardiologijos ir reabilitacijos klinika

Klaipėda LT-91131

0 studies enrolling now · 3 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Atrial Fibrillation, Prevention of Stroke or Systemic Embolism

Studies at this site

• Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial — Running, not enrolling
• A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD) — Completed
• A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early